U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07794592) titled 'A Study Comparing Two Ways of Taking Olomorasib (LY3537982) in Healthy Participants' on Aug. 26.
Brief Summary: The main purpose of this study is to compare how much and how quickly olomorasib gets into the bloodstream when it is taken in 2 different ways, and to check for any side effects. For each participant, the study will last about 6 weeks and will include 1 stay in the Clinical Research Unit (CRU) which consists of 7 nights.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: Olomorasib test
Administered orally
DRUG: Olomorasib reference
Administered orally
Recru...